Last call was the same. It is probably so you don't have much time to review the financials before the call. I will be interested to hear who is on the call on the Wall Street side. Mgt will probably try to spin the focus to biologics, the "next new thing". Hopefully they will find some good news to release. I don't expect the pps to fall much further, and who knows, maybe there is a pony in this pile of after all.
News 
Market Data 
Discover 
